Bayer to buy Merck consumer health business for $14.2 billion

Associated Press


Germany’s Bayer plans to buy U.S.-based Merck & Co.’s consumer health business, creating a combined medicine cabinet of household names from Bayer’s aspirin to Merck’s Claritin allergy pills.

The $14.2 billion deal announced Tuesday would vault Bayer AG atop the nonprescription medicine business across North and Latin America.

Don't Miss a Story

Sign up for our newsletter to receive daily news directly in your inbox.